Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Next Wave (India) is a WHO-GMP and PIC/S certified pharmaceutical company and contract development and manufacturing organization (CDMO) based in India. Established in 2005, the company operates state-of-the-art manufacturing facilities in Paonta Sahib, Himachal Pradesh, specializing in non-beta-lactam finished dosage forms including tablets, capsules, oral liquids, ointments, gels, and creams. Next Wave (India) serves both domestic and international markets across Southeast Asia, LATAM, and Africa, offering high-quality generic formulations and contract manufacturing services. Its product portfolio spans multiple therapeutic areas, including cardiovascular, anti-diabetic, anti-infective, and ophthalmic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Next Wave India.